what products does nath bio-genes (india) make

Nath Bio-Genes (India) Limited manufactures and markets hybrid seeds and GM seeds, along with growth supplements and related services to enhance crop yields and support sustainable agriculture practices in India.

what sector is nath bio-genes (india) in

Nath Bio-Genes (India) Limited operates in the agriculture sector, specifically focusing on seeds and related agricultural inputs, contributing to the farming and gardening industry in India.

who owns nath bio-genes (india)

Nath Bio-Genes (India) Limited is a public limited company, and while ownership is publicly held, it is rooted in the ethos of supporting Indian farmers and has been actively involved in the agricultural sector since its establishment.

when was nath bio-genes (india) founded

Nath Bio-Genes (India) Limited was founded on 14 July 1993 in Aurangabad, Maharashtra, India, and has been a significant player in the seed industry for over three decades.

Nath Bio-Genes (India) Limited (NATHBIOGEN) Share Price Today — ₹171.4

Nath Bio-Genes (India) Limited (NATHBIOGEN) live stock price is ₹171.4. Listed on BSE. Sector: Fast Moving Consumer Goods. Industry: Agricultural Food & other Products.

View Nath Bio-Genes (India) Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Fast Moving Consumer Goods sector.

Use our Stock CAGR Calculator to calculate returns for Nath Bio-Genes (India) Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

NATHBIOGEN

BSE

Nath Bio-Genes (India) Limited

Fast Moving Consumer Goods· Agricultural Food & other Products· INE448G01010· Scrip: 537291

EN हिन्दी ગુજરાતી मराठी

₹171.40

▲ 0.40 (+0.00%)

2026-05-27

BSE

₹171.40

▲ 0.40

+0.00%

241 trading days · 1Y period

TODAY (BSE)

Open171.80

High174.15

Low169.00

Prev Close171.00

Volume1,289

Value₹0.0Cr

L: 169.00H: 174.15

Info

Face Value₹10

Listed2014-01-28

ISININE448G01010

SeriesB

BSE Scrip537291

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+14.54%

PAT+138.08%

EPS+150.94%

Profitability

EBITDA Margin26.2%

Net Margin7.2%

TTM EBITDA M.15.6%

TTM Net M.11.3%

Dividend

Yield—

Latest DPS₹2

Payout Ratio150.4%

Growth+0.00%

TTM Revenue

₹356 Cr

TTM EBITDA

₹55 Cr

TTM PAT

₹40 Cr

TTM EPS

₹21.50

Rev/Share

₹187.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	37 Cr	34 Cr	10 Cr	4 Cr	3 Cr	₹1.33
2024-09-30	32 Cr	31 Cr	5 Cr	1 Cr	1 Cr	₹0.53
2024-06-30	244 Cr	210 Cr	35 Cr	34 Cr	34 Cr	₹17.77
2024-03-31	43 Cr	41 Cr	6 Cr	3 Cr	3 Cr	₹1.87
2023-12-31	32 Cr	30 Cr	9 Cr	5 Cr	4 Cr	₹2.02
2023-09-30	23 Cr	20 Cr	6 Cr	2 Cr	2 Cr	₹0.86
2023-03-31	45 Cr	44 Cr	4 Cr	2 Cr	1 Cr	₹0.76
2022-12-31	25 Cr	23 Cr	6 Cr	2 Cr	1 Cr	₹0.71

Shareholding Pattern

CURRENT — 2026-03-31

Promoter45.6%

FII0.2%

DII0.0%

Public54.4%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-08-14	Dividend	Dividend - Rs 2 Per Share
2024-08-12	Other	Annual General Meeting
2024-08-09	Dividend	Dividend - Rs 2 Per Share
2024-03-07	Other	Extra- Ordinary General Meeting
2023-07-04	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2022-06-23	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2021-08-18	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2020-07-16	Other	Annual General Meeting
2019-08-01	Other	Annual General Meeting
2018-07-26	Other	Annual General Meeting
2017-08-14	Other	Annual General Meeting
2016-07-19	Other	Annual General Meeting
2015-07-30	Other	Annual General Meeting

Earnings Transcripts

Nath Bio-Genes (India) Limited has informed the Exchange about Intimation of Conference Call

29 Apr 2026NSE1K chars

Read →

Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Transcript of concall'.

18 Nov 2025NSE52K chars

Read →

Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Investor Presentation'.

29 Apr 2025NSE8K chars

Read →

Nath Bio-Genes (India) Limited has informed the Exchange about CONFERENCE CALL

24 Apr 2025NSE1K chars

Read →

Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Investor Presentation on Financi...

25 Jan 2025NSE7K chars

Read →

Nath Bio-Genes (India) Limited has informed the Exchange about Investor Presentation

18 Jan 2024NSE10K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-05-27	171.26	174.89	169.36	172.20	40,108
2026-05-26	173.05	177.00	170.35	171.11	20,515
2026-05-25	172.82	178.79	172.82	175.92	29,603
2026-05-22	174.00	174.00	169.94	172.83	17,315
2026-05-21	168.54	176.02	166.92	170.53	1.30L
2026-05-20	160.00	168.78	159.83	166.88	19,262
2026-05-19	159.62	162.99	159.02	160.27	8,801
2026-05-18	160.92	160.92	153.63	158.30	35,110
2026-05-15	163.00	164.75	160.05	160.92	11,713
2026-05-14	166.49	167.00	160.10	160.77	47,158
2026-05-13	165.50	173.29	162.02	163.59	79,424
2026-05-12	168.00	172.00	162.00	163.34	42,691
2026-05-11	170.00	174.20	165.00	168.80	31,698
2026-05-08	176.00	176.98	170.60	171.21	28,517
2026-05-07	177.12	179.74	173.47	174.37	49,216
2026-05-06	179.40	179.80	173.18	177.12	64,871
2026-05-05	180.00	181.00	171.00	173.11	1.84L
2026-05-04	196.01	197.62	187.00	189.05	57,686
2026-04-30	199.01	204.00	192.00	196.01	4.73L
2026-04-29	172.01	181.30	171.62	180.79	38,678
2026-04-28	175.89	177.93	170.52	172.00	9,043
2026-04-27	171.90	178.95	168.01	173.78	21,482
2026-04-24	174.00	174.04	167.32	169.10	12,908
2026-04-23	171.35	177.35	169.24	171.66	52,334
2026-04-22	170.00	172.15	167.00	171.35	13,995
2026-04-21	169.62	173.88	169.62	170.74	9,312
2026-04-20	169.95	171.71	165.00	171.13	14,950
2026-04-17	167.28	170.37	163.98	167.71	13,947
2026-04-16	174.75	176.30	165.10	167.28	52,627
2026-04-15	173.00	178.00	172.94	174.75	40,091

Frequently Asked Questions

About

Nath Bio-Genes (India) Limited, incorporated in 1993, is an Indian company engaged in the production, processing, and marketing of hybrid and genetically modified (GM) seeds for field crops, vegetable crops, and plant nutrient supplements. The company operates in the agricultural sector, offering a range of high-yield seeds and related products to farmers, and has a notable product portfolio that supports crop improvement and soil health.

Advertisement

BOARD OF DIRECTORS

Satish Kaglliwal